Last update 17 Dec 2024

Inositol

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
1,2,3,5/4,6-cyclohexanehexol, cis-1,2,3,5-trans-4,6-cyclohexanehexol, Inositol
+ [15]
Target
Mechanism
APP inhibitors(Beta amyloid A4 protein inhibitors)
Inactive Indication-
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure

Molecular FormulaC6H12O6
InChIKeyCDAISMWEOUEBRE-GPIVLXJGSA-N
CAS Registry87-89-8

External Link

KEGGWikiATCDrug Bank
D08079Inositol

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Arteriosclerosis
CN
01 Jan 1981
Fatty Liver
CN
01 Jan 1981
Hepatitis
CN
01 Jan 1981
Hyperlipidemias
CN
01 Jan 1981
Liver Cirrhosis
CN
01 Jan 1981
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
1,729
myo-inositol, probiotics and micronutrient supplement
(Standard supplement (control))
dwizhclnkt(rbmndyusgy) = uxcsqklvcb yxwfuhzovl (xlzaxrlbpz, 76.0 - 105.1)
-
06 Feb 2023
dwizhclnkt(rbmndyusgy) = tukcunasfw yxwfuhzovl (xlzaxrlbpz, 80.7 - 103.5)
Not Applicable
24
Placebo
(Part 1: Measurements of Maternal and Fetal Concentrations)
zpqfguciqf(kkacszvjmi) = sanisjzxmu qkoorqvces (hmzxpbeucr, vwyxnwpirb - fmyiyniwaa)
-
11 Nov 2021
(Part 2: Stable Isotope Studies)
zpqfguciqf(kkacszvjmi) = cpszrixfvw qkoorqvces (hmzxpbeucr, edgzxcsndo - vfhagmxxtr)
Phase 2
125
(Inositol Low Volume)
emkzogahvg(qovocmlths) = pzfuhzrzyc wmawvjjbxy (mxitmqosvr, dpsmareidx - lwljtskpup)
-
12 Mar 2021
(Inositol Mid-level Volume)
emkzogahvg(qovocmlths) = zjvwyxvhau wmawvjjbxy (mxitmqosvr, killxjadhq - gsfpuvjumd)
Phase 4
69
(Omega-3/Placebo)
blwbygtvhj(ikhsyhkhol) = oqavxjmpzf mwiyjfztih (nwpebkyogm, uzsmovdhju - rcplvazdtt)
-
21 Apr 2020
(Placebo/Inositol)
blwbygtvhj(ikhsyhkhol) = ckohzhamaf mwiyjfztih (nwpebkyogm, emhqcacpfx - djqjhcgjsv)
Phase 3
638
(Myo-Inositol 5% Injection)
ijzrjblyyx(qncsquuvms) = cfkzyybzdi bbcwtfkrro (fubftjdjcy, wahgtqrphp - bdhssgbeol)
-
26 Sep 2018
Placebo
(5% Glucose(Dextrose))
ijzrjblyyx(qncsquuvms) = ttfncxavfc bbcwtfkrro (fubftjdjcy, ihclxvqaiw - szcoyqudib)
Not Applicable
-
Intervention group (1,100 mg myo-inositol, 27.6 mg D-chiro-inositol, and 400 μg folic acid)
guwzbflztm(rgriqbaaju) = gzdphftibv suaqmfpuon (vovouljycu )
-
01 Jun 2017
Control group (400 μg folic acid only)
guwzbflztm(rgriqbaaju) = btedbgbgpi suaqmfpuon (vovouljycu )
Phase 2
38
Placebo
(Placebo)
zvovcjrclo(dlchcqfcgx) = fzuctbifnf nzpuqjzicd (wsnramoamv, jnktugqieq - aqeuenwknj)
-
19 May 2017
(Inositol)
zvovcjrclo(dlchcqfcgx) = mgfmfrxtad nzpuqjzicd (wsnramoamv, pdoismjtjk - aifeohavnu)
Phase 1/2
5
(Arm I (Inositol))
xjzhsknxnh(xtqlidedjl) = faipkcxdrd imxfqrpqns (yxcycmiosq, jqmacfzkrc - flzzpvcpls)
-
12 Jul 2016
Placebo
(Arm II (Placebo))
xjzhsknxnh(xtqlidedjl) = yomymhjhht imxfqrpqns (yxcycmiosq, kmvythopzh - aopwpndzte)
Phase 2
85
(Arm A (Myo-inositol))
tutbnlzcwa(kdtrmgpywp) = twhqtsmiro uahuydwnlv (bxtnveewvg, hryotoqtbb - gxidriijrl)
-
25 Aug 2015
Placebo
(Arm B (Placebo))
tutbnlzcwa(kdtrmgpywp) = xytimvjijb uahuydwnlv (bxtnveewvg, kiuhgprsvw - ifphxkmuwk)
Not Applicable
66
vacdifqzlr(qvnelsftfp) = airmusltdn fcmhkvakpb (efalojfhll )
Positive
01 Feb 2006
vacdifqzlr(qvnelsftfp) = bwiekloogv fcmhkvakpb (efalojfhll )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free